Kang Zhang Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

1/2016	Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study).
1/2016	Joint Antiangiogenic Effect of ATN-161 and Anti-VEGF Antibody in a Rat Model of Early Wet Age-Related Macular Degeneration.
1/2016	Economic and Quality of Life Benefits of Anti-VEGF Therapy.
3/2015	Pharmacogenomics of response to anti-VEGF therapy in exudative age-related macular degeneration.
11/2013	Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP).
2/2013	JNK inhibition reduces apoptosis and neovascularization in a murine model of age-related macular degeneration.
1/2010	Slit-Robo signaling in ocular angiogenesis.
11/2009	Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity.
4/2008	Sequence- and target-independent angiogenesis suppression by siRNA via TLR3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kang Zhang Research Topics

Disease

40	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 04/2002
28	Neoplasms (Cancer) 12/2023 - 06/2011
23	Infections 02/2024 - 05/2014
14	Inflammation (Inflammations) 04/2024 - 08/2012
11	Glaucoma 01/2022 - 01/2011
11	Choroidal Neovascularization 01/2016 - 01/2006
8	Cataract (Cataracts) 09/2022 - 04/2006
7	Atrophy 12/2023 - 04/2002
7	COVID-19 12/2021 - 01/2020
7	Open-Angle Glaucoma (Glaucoma, Open Angle) 09/2016 - 02/2008
6	Retinitis Pigmentosa (Pigmentary Retinopathy) 06/2018 - 01/2006
5	Blindness (Hysterical Blindness) 06/2018 - 09/2006
5	Geographic Atrophy 03/2014 - 10/2008
4	Adenocarcinoma of Lung 01/2024 - 01/2016
4	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2017
4	Retinal Degeneration 06/2009 - 04/2002
3	Body Weight (Weight, Body) 04/2024 - 05/2022
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 11/2019
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2019
3	Hepatocellular Carcinoma (Hepatoma) 03/2021 - 01/2018
3	Atherosclerosis 01/2021 - 01/2018
3	Alzheimer Disease (Alzheimer's Disease) 10/2020 - 09/2006
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2017
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018 - 01/2017
3	Pathologic Neovascularization 01/2016 - 11/2009
3	Aneuploidy (Aneuploid) 11/2015 - 01/2014
3	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2015 - 08/2008
3	Retinal Diseases 03/2014 - 01/2006
3	Vascular Diseases (Vascular Disease) 06/2012 - 04/2008
3	Familial Exudative Vitreoretinopathies 03/2011 - 03/2004
2	Necrosis 12/2023 - 12/2007
2	Chronic Kidney Failure (Chronic Renal Failure) 12/2023 - 12/2022
2	Cognitive Dysfunction 12/2023 - 01/2016
2	Ocular Hypertension (Glaucoma, Suspect) 07/2023 - 01/2011
2	Pneumonia (Pneumonitis) 10/2022 - 02/2021
2	Eye Diseases (Eye Disease) 07/2022 - 01/2020
2	Diarrhea 06/2022 - 01/2022
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2020
2	Disease Progression 01/2021 - 08/2015
2	Heart Failure 01/2021 - 07/2016
2	Stomach Neoplasms (Stomach Cancer) 10/2020 - 03/2020
2	Virus Diseases (Viral Diseases) 10/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

33	Proteins (Proteins, Gene)FDA Link 09/2023 - 03/2004
23	Retinaldehyde (Retinal)IBA 07/2023 - 04/2002
11	MicroRNAs (MicroRNA)IBA 04/2024 - 01/2016
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 04/2008
8	RNA (Ribonucleic Acid)IBA 12/2023 - 11/2015
8	DNA (Deoxyribonucleic Acid)IBA 03/2019 - 06/2009
6	CytokinesIBA 04/2024 - 11/2011
6	LipidsIBA 12/2023 - 10/2010
5	Amino Acids FDA Link 02/2024 - 03/2002
5	Interleukin-6 (Interleukin 6)IBA 12/2023 - 12/2016
5	VaccinesIBA 06/2023 - 05/2017
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2012
4	Crystallins (Crystallin)IBA 09/2022 - 07/2015
4	Transcription Factors (Transcription Factor)IBA 01/2022 - 04/2006
4	AntibodiesIBA 12/2020 - 02/2008
4	Ranibizumab (Lucentis)FDA Link 01/2016 - 12/2007
4	Complement System Proteins (Complement)IBA 03/2014 - 02/2006
4	Retinal Pigments (Pigments, Visual)IBA 10/2010 - 10/2008
3	CreatinineIBA 12/2023 - 08/2014
3	LanosterolIBA 09/2022 - 07/2015
3	InflammasomesIBA 05/2022 - 07/2014
3	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 10/2014
3	Cell-Free Nucleic AcidsIBA 03/2021 - 11/2015
3	Serine (L-Serine)FDA Link 01/2018 - 01/2004
3	Verteporfin (Visudyne)FDA Link 01/2015 - 12/2007
3	Fatty Acids (Saturated Fatty Acids)IBA 04/2014 - 06/2009
3	Complement Factor H (Factor H)IBA 08/2012 - 09/2006
3	PeripherinsIBA 01/2006 - 04/2002
2	IronIBA 04/2024 - 08/2022
2	baicalinIBA 02/2024 - 12/2022
2	Ribosomal DNA (rDNA)IBA 02/2024 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 12/2023
2	AntioxidantsIBA 12/2023 - 11/2019
2	InterleukinsIBA 12/2023 - 12/2016
2	Aquaporin 4IBA 12/2023 - 05/2017
2	Hemoglobins (Hemoglobin)IBA 12/2023 - 01/2022
2	HMGB1 Protein (HMG1)IBA 12/2022 - 08/2017
2	Messenger RNA (mRNA)IBA 12/2022 - 08/2017
2	CateninsIBA 10/2022 - 01/2017
2	Fluorescein (Funduscein)FDA LinkGeneric 09/2022 - 02/2003
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 09/2020
2	C-Reactive ProteinIBA 01/2022 - 10/2020
2	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 01/2022 - 01/2019
2	Tryptophan (L-Tryptophan)FDA Link 01/2022 - 10/2014
2	jasmonic acid (jasmonate)IBA 01/2022 - 01/2022
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 11/2018
2	EnzymesIBA 10/2020 - 10/2010
2	Peptides (Polypeptides)IBA 10/2020 - 02/2008
2	Circulating Tumor DNAIBA 01/2020 - 11/2015

Therapy/Procedure

28	Therapeutics 10/2022 - 10/2008
4	Transplantation 01/2024 - 01/2013
3	Radiotherapy 01/2024 - 10/2023
3	Intravitreal Injections 02/2015 - 01/2006
2	Drug Therapy (Chemotherapy) 01/2024 - 10/2020
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 12/2016
2	Injections 10/2022 - 02/2015
2	Length of Stay 10/2022 - 02/2021
2	Lenses 09/2022 - 07/2015